Koers Ambu A/S Nasdaq Copenhagen
Aandelen
DK0060591204
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 5,28 mld. 757 mln. 708 mln. | Omzet 2025 * | 5,98 mld. 857 mln. 801 mln. | Marktkapitalisatie | 29,97 mld. 4,29 mld. 4,01 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 411 mln. 58,88 mln. 55,05 mln. | Nettowinst (verlies) 2025 * | 615 mln. 88,1 mln. 82,38 mln. | EV/omzet 2024 * | 5,71 x |
Nettoschuld 2024 * | 195 mln. 27,93 mln. 26,12 mln. | Nettoliquiditeiten 2025 * | 159 mln. 22,8 mln. 21,32 mln. | EV/omzet 2025 * | 4,98 x |
K/w-verhouding 2024 * |
73,1
x | K/w-verhouding 2025 * |
48,9
x | Werknemers | - |
Dividendrendement 2024 * |
0,33% | Dividendrendement 2025 * |
0,46% | Vrij verhandelbaar | 64,63% |
Recentste transcriptie over Ambu A/S
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 51 | 17-12-19 | |
Director of Finance/CFO | 40 | 01/01 | |
Finn Möhring
CTO | Chief Tech/Sci/R&D Officer | - | 01-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jørgen Jensen
CHM | Chairman | 56 | 09-12-20 |
Christian Sagild
BRD | Director/Board Member | 64 | 01-01-12 |
Director/Board Member | 54 | 01-01-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,72% | 184 mld. | |
-2,60% | 107 mld. | |
-3,79% | 67,78 mld. | |
+2,66% | 50,66 mld. | |
+16,39% | 47,64 mld. | |
+4,60% | 41,12 mld. | |
+1,38% | 26,3 mld. | |
+1,52% | 26,04 mld. | |
+15,06% | 25,4 mld. |